By Shaheen Limbada, Executive Vice President, Global Operations, Veristat, Brenda Muskat, Global Clinical Project Director, Veristat, and Amy Bossoms, Senior Project Manager, Veristat
The focus on delivering patient-centric practices to improve clinical trial participation by reducing the burden on patients is the cornerstone of clinical research excellence. Over the last few years, there has been a shift to bring the clinical trial to the patient’s home, an evident disruption of historical clinical trial conduct practices. While adoption has not been widespread, the COVID-19 pandemic has rapidly turned this ideology into a necessary reality.
Veristat understands how challenging it is to pivot to virtual and hybrid clinical trials successfully. With multiple virtual trials running right now, the company has designed a customized virtual/hybrid trial ecosystem that satisfies regulators, sponsors and the patients’ needs.
Read this webinar presentation as panelists share lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials’ conduct.